JNJ is a buy as stocks slide after its quarterly earnings report

A bottle of Johnson & Johnson brand lotion for sale at a drugstore in Salt Lake City, Utah on Thursday, Feb. 25, 2021.

George Frey | Bloomberg | Getty Images

Johnson & Johnson (JNJ) released second-quarter results on Tuesday that beat analysts’ expectations.

Leave a Comment